![]() |
![]() |
| Clin Shoulder Elb > Volume 29(2); 2026 > Article |
|
Author contributions
Conceptualization: ARZ. Data curation: ARZ. Formal analysis: ARZ. Investigation: ARZ. Methodology: ARZ. Project administration: ARZ. Resources: ARZ. Software: ARZ. Supervision: US. Validation: ARZ. Visualization: ARZ. Writing – original draft: ARZ, EM, GQC, ARZ. Writing – review & editing: ARZ, US. All authors read and agreed to the published version of the manuscript.
Conflict of interest
Outside of this work, Umasuthan Srikumaran serves as a board or committee member for American Academy of Orthopaedic Surgeons, American Shoulder and Elbow Surgeons, and International Congress of Shoulder and Elbow Surgery; reports stock or stock options from ROM3, Sonogen, and Tigon Medical; is a paid consultant for, and receives intellectual property royalties from, Fx shoulder and Tigon Medical; receives other financial or material support from Arthrex, Depuy–a Johnson & Johnson Company, and Thieme; and has been a paid presenter or speaker for, and received research support from, Fx Shoulder. The remaining authors have no disclosures to report.
| Variable | Total sample (n=64,089) | Arthroscopic RCR, unmatched (n=54,595) | Open RCR, unmatched (n=9,494) | P-value |
|---|---|---|---|---|
| Age (yr) | 59.11±10.66 | 58.97±10.64 | 59.95±10.73 | <0.001* |
| Sex | 0.413a) | |||
| Female | 27,054 (42.2) | 23,001 (42.1) | 4,053 (42.7) | |
| Male | 37,034 (57.8) | 31,593 (57.9) | 5,441 (57.3) | |
| Non-binary | 1 (0.0) | 1 (0.0) | 0 | |
| BMI (kg/m2) | 31.15±6.65 | 31.07±6.61 | 31.58±6.84 | <0.001* |
| Non-independent functional status | 270 (0.4) | 219 (0.4) | 51 (0.5) | 0.071 |
| ASA classification ≥3 | 23,930 (37.3) | 19,964 (36.6) | 3,966 (41.8) | <0.001* |
| Smoker | 9,245 (14.4) | 7,601 (13.9) | 1,644 (17.3) | <0.001* |
| Diabetes mellitus | 11,170 (17.4) | 9,410 (17.2) | 1,760 (18.5) | 0.002* |
| Hypertension requiring medication | 31,172 (48.6) | 26,161 (47.9) | 5,011 (52.8) | <0.001* |
| History of severe COPD | 2,112 (3.3) | 1,692 (3.1) | 420 (4.4) | <0.001* |
| Ascites (liver disease) | 12 (0.0) | 7 (0.0) | 5 (0.1) | 0.023a),* |
| Heart failure in the 30 days before surgery | 360 (0.6) | 325 (0.6) | 35 (0.4) | 0.008* |
| Disseminated cancer | 58 (0.1) | 49 (0.1) | 9 (0.1) | 1.000a) |
| Currently on dialysis (renal failure) | 79 (0.1) | 68 (0.1) | 11 (0.1) | 0.949 |
| Ventilator use | 3 (0.0) | 3 (0.0) | 0 | 1.000a) |
| Bleeding disorder | 1,040 (1.6) | 866 (1.6) | 174 (1.8) | 0.087 |
| Preoperative pRBC transfusion <72 hours before surgery | 3 (0.0) | 2 (0.0) | 1 (0.0) | 0.382a) |
| Variable | Total sample (n=18,988) | Arthroscopic RCR, matched (n=9,494) | Open RCR, matched (n=9,494) | P-value |
|---|---|---|---|---|
| Age (yr) | 59.95±10.52 | 59.96±10.31 | 59.95±10.73 | 0.925 |
| Sex | 0.747a) | |||
| Female | 8,129 (42.8) | 4,076 (42.9) | 4,053 (42.7) | |
| Male | 10,859 (57.2) | 5,418 (57.1) | 5,441 (57.3) | |
| BMI (kg/m2) | 31.59±6.86 | 31.60±6.88 | 31.58±6.84 | 0.869 |
| Non-independent functional status | 114 (0.6) | 63 (0.7) | 51 (0.5) | 0.301 |
| ASA classification ≥3 | 7,892 (41.6) | 3,926 (41.4) | 3,966 (41.8) | 0.566 |
| Smoker | 3,273 (17.2) | 1,629 (17.2) | 1,644 (17.3) | 0.788 |
| Diabetes mellitus | 3,497 (18.4) | 1,737 (18.3) | 1,760 (18.5) | 0.690 |
| Hypertension requiring medication | 9,997 (52.6) | 4,986 (52.5) | 5,011 (52.8) | 0.727 |
| History of severe COPD | 853 (4.5) | 433 (4.6) | 420 (4.4) | 0.674 |
| Ascites (liver disease) | 9 (0.0) | 4 (0.0) | 5 (0.1) | 1.000a) |
| Heart failure in the 30 days before surgery | 65 (0.3) | 30 (0.3) | 35 (0.4) | 0.619 |
| Disseminated cancer | 20 (0.1) | 11 (0.1) | 9 (0.1) | 0.823 |
| Currently on dialysis (renal failure) | 23 (0.1) | 12 (0.1) | 11 (0.1) | 1.000 |
| Ventilator use | 0 | 0 | 0 | NA |
| Bleeding disorder | 362 (1.9) | 188 (2.0) | 174 (1.8) | 0.490 |
| Preoperative pRBC transfusion <72 hours before surgery | 1 (0.0) | 0 | 1 (0.0) | 1.000a) |
| Variable | Total sample (n=18,988) | Arthroscopic RCR, matched (n=9,494) | Open RCR, matched (n=9,494) | Percent difference (%) | P-value |
|---|---|---|---|---|---|
| Operative time (min) | 86.38±42.73 | 91.82±43.71 | 80.93±41.02 | +13.46 | <0.001* |
| wRVU | 13.01±1.99 | 15.00±0.00 | 11.03±0.23 | +35.99 | <0.001* |
| wRVU/min | 0.18±0.08 | 0.20±0.09 | 0.17±0.07 | +17.65 | <0.001* |
| Reimbursement rate ($) | 5.90±2.61 | 6.42±2.80 | 5.39±2.29 | +19.11 | <0.001* |
| Revenue per case ($) | 420.98±64.44 | 485.20±0.00 | 356.77±7.54 | +36.00 | <0.001* |
Values presented as mean±standard deviation. The Centers for Medicare and Medicaid Services conversion factor for January–December 2025 ($32.3465) was used to determine reimbursement rate and revenue per case. Percent difference was calculated as: (arthroscopic RCR–open RCR)/open RCR.
wRVU: work relative value unit, RCR: rotator cuff repair.
| Variable | Total sample (n=18,988) | Arthroscopic RCR, matched (n=9,494) | Open RCR, matched (n=9,494) | P-value |
|---|---|---|---|---|
| Length of total hospital stay (day) | 0.25±1.90 | 0.15±1.63 | 0.34±2.13 | <0.001* |
| Mortality | 8 (0.0) | 2 (0.0) | 6 (0.1) | 0.289a) |
| Any complication | 241 (1.3) | 100 (1.1) | 141 (1.5) | 0.010* |
| Any minor complication | 150 (0.8) | 58 (0.6) | 92 (1.0) | 0.007* |
| Superficial surgical site infection | 56 (0.3) | 1 9 (0.2) | 37 (0.4) | 0.023* |
| Urinary tract infection | 43 (0.2) | 15 (0.2) | 28 (0.3) | 0.067 |
| Vein thrombosis requiring therapy | 44 (0.2) | 23 (0.2) | 21 (0.2) | 0.880a) |
| Bleeding resulting in transfusion | 8 (0.0) | 2 (0.0) | 6 (0.1) | 0.289a) |
| Any major complication | 108 (0.6) | 49 (0.5) | 59 (0.6) | 0.385 |
| Ventilator use >48 hours | 6 (0.0) | 1 (0.0) | 5 (0.1) | 0.219a) |
| Unplanned intubation | 10 (0.1) | 4 (0.0) | 6 (0.1) | 0.752 |
| Pneumonia | 32 (0.2) | 16 (0.2) | 16 (0.2) | 1.000 |
| Myocardial infarction | 8 (0.0) | 3 (0.0) | 5 (0.1) | 0.727a) |
| Stroke | 6 (0.0) | 3 (0.0) | 3 (0.0) | 1.000a) |
| Progressive renal insufficiency/acute renal failure requiring dialysis | 0 | 0 | 0 | NA |
| Pulmonary embolism | 36 (0.2) | 17 (0.2) | 19 (0.2) | 0.868 |
| Deep surgical site infection | 17 (0.1) | 2 (0.0) | 15 (0.2) | 0.004* |
| Wound dehiscence | 5 (0.0) | 2 (0.0) | 3 (0.0) | 1.000a) |
| Sepsis or septic shock | 8 (0.0) | 3 (0.0) | 5 (0.1) | 0.727a) |

![]() |
![]() |